HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcel Rozencweig Selected Research

Platinum

11/2009Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marcel Rozencweig Research Topics

Disease

2Prostatic Neoplasms (Prostate Cancer)
01/2012 - 11/2009
1Neoplasms (Cancer)
01/2012
1Pain (Aches)
11/2009

Drug/Important Bio-Agent (IBA)

2satraplatin (JM 216)IBA
01/2012 - 11/2009
1GemcitabineFDA Link
01/2012
1PlatinumIBA
11/2009
1Prednisone (Sone)FDA LinkGeneric
11/2009

Therapy/Procedure

1Drug Therapy (Chemotherapy)
11/2009